In 1953, three scientists (James Watson, Francis Crick, and Maurice Wilkins) published papers in Nature magazine detailing the structure of DNA. 50 years later to the day, the Human Genome Project declared that the first human genome was on the verge of being sequenced.
read moreCoriell Institute has partnered with IBM to create a new, for-profit genomic information storage and interpretation spin-off company: Coriell Life Sciences (CLS).
read moreThe California Institute for Regenerative Medicine (CIRM), one of the world's foremost supporters of stem cell science, has awarded Coriell $10M to supply induced pluripotent stem (iPS) cell lines as part of a cutting-edge research endeavor.
read moreThe Philadelphia Business Journal's John George recently talked with Coriell President and CEO Dr. Michael Christman to discuss the Institute's landmark $10 million award from the California Institute for Regenerative Medicine.
read moreThis February 12 marked the first annual recognition of Darwin Day, a recently conceived holiday designed to commemorate the birth of history's favorite naturalist, Charles Darwin, on February 12, 1809.
read moreThe Institute for Pharmacogenomics and Individualized Therapy (IPIT) at the University of North Carolina at Chapel Hill has honored Coriell Institute's President and CEO, Dr. Michael Christman, as this year's recipient of the Patient Service Award.
read moreCoriell Institute's President and CEO, Dr. Michael Christman, has been invited to speak at the Personalized Medicine World Conference (PMWC) 2013, a prestigious gathering of some of the most influential figures in the health and medical fields.
read moreB2Bioworld, an online business and technology publication, spotlights Coriell in an in-depth discussion with Institute President and CEO, Dr. Michael Christman.
read moreIn a November feature on prominent regional business figures, South Jersey Biz magazine named Coriell Institute's Michael Christman, PhD, one of 2012's top executives.
read moreDr. Michael Christman, Coriell Institute's President and CEO, shares his vision of personalized medicine in the clinical setting with PharmaPhorum, a hub of pharmaceutical industry publications, news, and influential discussion.
read more